---
title: "SUPN 股票警报：Halper Sadeh LLC 正在调查 Supernus 制药公司是否为其股东争取到了公平的价格"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/297401736.md"
description: "Halper Sadeh LLC 正在调查 Supernus Pharmaceuticals, Inc. 在拟议出售给 Indivior Pharmaceuticals 的过程中是否为股东获得了公平的价格。该律师事务所指控存在潜在的信托责任违反和联邦证券法的违规行为，理由是未能确保最佳价格、未进行公平的销售流程或未披露重要信息。鼓励股东联系该事务所，讨论他们在此次交易中的权利和选择"
datetime: "2026-08-29T11:32:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297401736.md)
  - [en](https://longbridge.com/en/news/297401736.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297401736.md)
generator: "portal-rs"
---

# SUPN 股票警报：Halper Sadeh LLC 正在调查 Supernus 制药公司是否为其股东争取到了公平的价格

**SUPN Stock Alert: Halper Sadeh LLC is Investigating Whether Supernus Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders**

***Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.***

***The proposed transaction may contain terms that could limit superior competing offers.***

***Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation.******We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.***

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) to Indivior Pharmaceuticals, Inc. for 1.5401 common shares of Indivior for each share of Supernus.

Halper Sadeh encourages Supernus shareholders to **click here to learn more about their rights and options**or contact Daniel Sadeh or Zachary Halper **free of charge** at (212) 763-0060 or **sadeh@halpersadeh.com** or **zhalper@halpersadeh.com**.

The investigation concerns whether Supernus and its board of directors violated the federal securities laws and/or breached their fiduciary duties by failing to: (1) obtain the best possible price for Supernus shareholders; (2) conduct a fair sales process free of any conflicts of interests; and (3) disclose all material information for Supernus shareholders to evaluate the transaction.

On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures, or other relief and benefits.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Halper Sadeh LLC  
One World Trade Center  
85th Floor  
New York, NY 10007  
Daniel Sadeh, Esq.  
Zachary Halper, Esq.  
(212) 763-0060  
sadeh@halpersadeh.com  
zhalper@halpersadeh.com  
https://www.halpersadeh.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20260829451217/en/

### 相关股票

- [SUPN.US](https://longbridge.com/zh-CN/quote/SUPN.US.md)
- [INDV.US](https://longbridge.com/zh-CN/quote/INDV.US.md)

## 相关资讯与研究

- [Supernus 制药的管理层出席了 Cantor 全球医疗保健会议的炉边谈话](https://longbridge.com/zh-CN/news/297827223.md)
- [Great Lakes Advisors LLC 收购了 29,800 股 Supernus 制药公司 $SUPN](https://longbridge.com/zh-CN/news/296676820.md)
- [美股夜盘异动：Immuron 夜盘跌 3.33%，资金流向异常引波动，无利好支撑警惕回调风险](https://longbridge.com/zh-CN/news/298245784.md)
- [Alembic Pharmaceuticals 在迪拜设立全资子公司以促进全球扩张](https://longbridge.com/zh-CN/news/298223880.md)
- [DSGR 股票警报：Halper Sadeh LLC 正在调查 Distribution Solutions Group, Inc.是否为其股东争取到了合理的价格](https://longbridge.com/zh-CN/news/298112585.md)

---
> **免责声明: 本文仅供参考，不构成任何投资建议。**